| Revenue growth | Q2 +38.6% YoY; H1 +37.1% YoY |
|---|---|
| Margins | Q2 EBITDA margin 14.0% (+460bps); Q1 lifted by ASP gain |
| Demand visibility | Healthy Acetone and Phosphorus demand; some export delays |
| Management confidence | Reiterated FY27 guidance, excluding price and FX effects |
Growth
H1 EBITDA Rs148.0cr (+106.6%), margin 17.5%; H1 PAT Rs99.0cr (+138.9%). Q1 ASP gain (~Rs25cr) normalised in Q2.
Outlook
FY27 guidance: revenue Rs1,550–1,650cr, EBITDA Rs240–250cr, excluding price and FX effects. Phase I capex Rs250–300cr; Phase II from H2FY28.
Risks
Middle East freight and vessel shortages delayed exports. H1 working-capital outflow Rs141.3cr; receivables and inventory rose sharply.
Investor Presentation filed with BSE, NSE: PRASOLCHEM. Summary written with AI assistance from the document.
Prasol Chemicals Ltd: key numbers
- Share price
- ₹817.25
- Market cap
- ₹4,837 Cr
- Revenue (annual)
- ₹1,233 Cr
- Net profit (annual)
- ₹83.12 Cr
- Promoter holding
- 75.25%
- FII holding
- 0.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prasol Chemicals Ltd
All →Prasol Chemicals Q2 FY27 Results: Net Profit ₹38 Cr, Up 122.2% YoY
Prasol Chemicals Ltd reported revenue from operations of ₹412.6 Cr (+38.6% YoY) and net profit of ₹38 Cr (+122.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹38 Cr · +122.2% YoY
Prasol Chemicals Board Meeting Date
Prasol Chemicals gives prior intimation of a board meeting on 2 November 2026 to consider unaudited results for the quarter and half year ended September 2026. The trading window remains closed until 48 hours after the results.
Prasol Chemicals Other Announcement
Prasol Chemicals Ltd has filed its shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Prasol Chemicals Other Announcement
Prasol Chemicals Limited updated its Corporate Identification Number (CIN) from "U99999MH1992PLC065026" to "L99999MH1992PLC065026" following its recent equity listing.
Prasol Chemicals Earnings Call Transcript: Key Takeaways
Prasol Chemicals reported record Q1 FY27 performance with revenue up 36% YoY. Strategy focuses on expanding high-margin acetone and phosphorus derivatives via massive capex and R&D.
- Call
- Guides 26% growth
Prasol Chemicals Investor Presentation: Key Takeaways
Prasol Chemicals reported record Q1FY27 performance following its Sep 2026 IPO, driven by volume growth and improved product mix in Acetone and Phosphorus derivatives.
- Call
- Guides 143% growth